ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Abstracts tagged "Tuberculosis"

  • Abstract Number: 1153 • ACR/ARP Annual Meeting 2019

    Double Trouble: Utility of Serial TB Screening in a Rheumatology Clinic Serving a Foreign-Born Population

    Alice Fike1, Yanira Ruiz-Perdomo 1 and James Katz 1, 1NIAMS, BETHESDA, MD

    Background/Purpose: The potential for reactivation of tuberculosis (TB) in patients treated with anti-TNF or other immunosuppressive agents has been well described.  Interferon-gamma release assays (IGRA)…
  • Abstract Number: 1802 • ACR/ARP Annual Meeting 2019

    Utility of Repeat Latent Tuberculosis Testing in Patients Taking Biologics

    Urmi Khanna1, Ariana Ellis 2, AbdulAziz Galadari 3, Jeffery Hu 4, Josh Gallop 5, M. Elaine Husni 6 and Anthony Fernandez 7, 1Department of Dermatology , Cleveland Clinic, Cleveland, OH, 2Northeast Ohio Medical University, Cleveland, OH, 3Cleveland Clinic, Abu Dhabi, Cleveland, 4Case Western Reserve University, Cleveland, 5Cleveland Clinic Lerner College of Medicine, Cleveland, OH, 6Department of Rheumatologic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH, 7Department of Dermatology and Pathology, Cleveland Clinic, Cleveland, OH

    Background/Purpose: Guidelines for repeat Latent Tuberculosis Infection (LTBI) testing while on biologics are not clearly defined. The American College of Rheumatology recommends repeat LTBI screening…
  • Abstract Number: 2097 • ACR/ARP Annual Meeting 2019

    Tuberculin Skin Test and Quantiferon®-TB Gold In-Tube Test for Latent Tuberculosis Before Biologic Treatments: Lower Agreement Rate in Spondyloarthropathies Compared to Rheumatoid Arthritis

    Ufuk İlgen1, Sezin Turan 1, Hakan Emmungil 1, Alper Sarı 2, Abdulsamet Erden 2, Levent Kilic 3, Ömer Karadağ 2, Sedat Kiraz 3, Ali İhsan Ertenli 4, Orhan Küçükşahin 5, Şükran Erten 6, Zeynel Abidin Akar 7, Burak Öz 7, Süleyman Serdar Koca 8, Cemal Bes 9, Nilufer Alpay-Kanitez 10, Emre Tekgöz 11, Seda Çolak 11, Muhammet Çınar 11, Sedat Yılmaz 11, Veli Yazısız 12, Mustafa Ender Terzioğlu 12, Ayşe Bahar Keleşoğlu Dinçer 13, Aşkın Ateş 13, Rıdvan Mercan 14, Onay Gercik 15, Servet Akar 16, Mehmet Pamir Atagündüz 17, Gezmiş Kimyon 18, Emel Gönüllü 19, Emine Duygu Ersözlü 20, Müge Aydın Tufan 21, Burcu Yağız 22, Belkıs Nihan Coşkun 23, Yavuz Pehlivan 22, Ediz Dalkılıç 22 and Umut Kalyoncu 24, 1Trakya University, Edirne, Turkey, 2Hacettepe University, Ankara, Turkey, 3Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey, 4Hacettepe University Vasculitis Centre, Ankara, Turkey, Ankara, Turkey, 5Liv Hospital, Ankara, Turkey, 6Yıldırım Beyazıt University, Ankara, Turkey, 7Fırat University, Elazığ, Turkey, 8Fırat University School of Medicine Division of Rheumatology, Elazığ, Turkey, 9University of Medical Sciences, İstanbul, Turkey, 10Koc University School of Medicine, Division of Rheumatology, İstanbul, Turkey, 11University of Medical Sciences, Ankara, Turkey, 12Akdeniz University, Antalya, Turkey, 13Ankara University, Ankara, Turkey, 14Namık Kemal University, Tekirdağ, Turkey, 15Izmir Katip Celebi University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, İzmir, Turkey, 16Izmir Katip Celebi University, Faculty of Medicine, Division of Rheumatology, İzmir, Turkey, 17Marmara University, İstanbul, Turkey, 18Mustafa Kemal University, Hatay, Turkey, 19Sakarya University, Sakarya, Turkey, 20Adana State Hospital, Adana, Turkey, 21Başkent University, Adana, Turkey, 22Uludağ University, Bursa, Turkey, 23Uludağ University, Bursa, 24Hacettepe University Department of Rheumatology, Ankara, Turkey

    Background/Purpose: Screening for and the treatment of latent tuberculosis is recommended in patients with inflammatory arthritides prior to biologic treatments, particularly the TNF inhibitors. The…
  • Abstract Number: 2098 • ACR/ARP Annual Meeting 2019

    Distinctive Pattern of LTBI Screening Parameters in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) in Endemic Areas

    Andrea Shimabuco 1, Ana Cristina de Medeiros Ribeiro 2, Renata Miossi 3, Karina Bonfiglioli 3, Julio Cesar Bertacini Moraes 3, Celio Gonçalves 3, Percival Sampaio-Barros 3, Claudia Goldenstein-Schainberg 3, Fernando Henrique Souza 3, Leandro Prado 3, Michelle Remião Ugolini-Lopes 4, Emily Yuki 5, Eloisa Bonfa 6 and Carla Gonçalves Schahin Saad3, 1Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil, 2Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Sao Paulo, Brazil, 3Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 4Rheumatology Division - Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo (FMUSP), Sao Paulo, Sao Paulo, Brazil, 5Rheumatology Division, Hospital das Clinicas, Faculdade de Medicina da Universidade de Sao Paulo (HCFMUSP), Sao Paulo, Brazil., São Paulo, Brazil, 6Rheumatology Division, Hospital das Clinicas, Faculdade de Medicina da Universidade de Sao Paulo (HCFMUSP), Sao Paulo, Brazil., Sao Paulo, Sao Paulo, Brazil

    Background/Purpose: Despite late tuberculosis infection (LTBI) screening before anti-TNF treatment, TB reactivation/new exposure in endemic areas remains a relevant problem. The specific analysis of Ankylosing…
  • Abstract Number: 1324 • ACR/ARHP Annual Meeting 2016

    The Result of Follow-up Interferon-Gamma-Release Assays in Patients with Rheumatic Disease Receiving Biologic Agents in a Japanese Hospital

    Yasuhiro Suyama1, Haruki Sawada2, Yukihiko Ikeda3, Rui Kawato4, Sakura Tamaki4, Mitsumasa Kishimoto1 and Masato Okada1, 1Immuno-Rheumatology Center, St. Luke's International Hospital, Tokyo, Japan, 2Immuno-rheumatology Center, St. Luke's International Hospital, Tokyo, Japan, 3Immune-Rheumatology center, St. Luke's International Hospital, Tokyo, Japan, 4Immuno rheumatology center, St. Luke's International Hospital, Tokyo, Japan

    Background/Purpose: Active tuberculosis (TB) is one of the most devastating side effects of biologic agents use. Several guidelines for the prevention of biologic agents-related infections…
  • Abstract Number: 1350 • ACR/ARHP Annual Meeting 2015

    Multi-Targeted Loop-Mediated Isothermal Amplification for Rapid Diagnosis of Osteoarticular Tuberculosis in 60 Minutes: Experience from North India

    Kusum Sharma1, Aman Sharma2 and Mandeep Dhillon3, 1Department of Medical Microbiology,, PGIMER,, Chandigarh, India, 2Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India, 3Department of Ortho[aedics,, PGIMER,, Chandigarh, India

    Background/Purpose: Loop-mediated Isothermal Amplification (LAMP) is a promising nucleic-acid amplification assay. Prompt and accurate diagnosis of Osteoarticular tuberculosis (OATB) is required for early treatment, better…
  • Abstract Number: 1364 • ACR/ARHP Annual Meeting 2013

    Detection of Latent Tuberculosis Infection in Rheumatologic Diseases Before Anti-TNFα Therapy: Tuberculin Skin Test Versus IFN-γ Assay

    Suleyman Ozbek1, Ismail Hanta2, Sedat Kuleci3, Gulsah Seydaoglu3 and Ezgi Ozyilmaz3, 1Division of Rheumatology, Cukurova University Faculty of Medicine, Adana, Turkey, 2Pulmonary, Cukurova University, Adana, Turkey, 3Cukurova University, Adana, Turkey

    Background/Purpose: We aimed to evaluate tuberculin skin test (TST) and interferon-gamma (IFN-γ) test results for latent tuberculosis infection (LTBI) in patients with rheumatologic diseases prior…
  • Abstract Number: 1137 • ACR/ARHP Annual Meeting 2013

    Evaluating Indeterminate Quantiferon-TB Gold In-Tube Results in Patients With Chronic Inflammatory Diseases On Immunosuppressive Therapy

    Cassandra Calabrese1, Robert A. Overman2,3, Stacie Dusetzina4 and Rula Hajj-Ali5, 1Cleveland Clinic, Cleveland, OH, 2Eshelman School of Pharmacy - Division of Pharmaceutical Policy and Outcomes, University of North Carolina, Chapel Hill, NC, 3Rheumatology, Cleveland Clinic, Cleveland, OH, 4Epidemiology, School of Medicine and Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Raleigh-Durham, NC, 5Cleveland Clinic Foundation, Cleveland, OH

    Background/Purpose: The Quantiferon test (QFT) is used to for screen for tuberculosis in patients with autoinflammatory conditions (IC) prior to the use of  immunosuppressant medications. …
  • Abstract Number: 316 • ACR/ARHP Annual Meeting 2013

    Quantiferon-TB Test Can Be Usefull For Decision Of Anti-Tuberculosis Prophylaxis During Anti-TNF Treatment: Result Of Real Life

    Umut Kalyoncu1, Levent Kilic1, Ahmet Cagkan Inkaya2, Omer Karadag3, Sule Apras Bilgen4, Ali Akdogan4, Sedat Kiraz5 and Ihsan Ertenli3, 1Rheumatology, Hacettepe University School of Medicine, Ankara, Turkey, 2infectious disease, Hacettepe University, Faculty of Medicine, Ankara, Turkey, 3Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, 4Rheumatology, Hacettepe University, Faculty of Medicine, Ankara, Turkey, 5Division of Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey

    Background/Purpose: Anti-tumor necrosis factor (TNF) treatments may increase tuberculosis. Most of the national guidelines recommend tuberculin skin test (TST) for screening of latent tuberculosis. However,…

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology